Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy-induced peripheral neuropathy.

Stefan Quasthoff1, Hans Peter Hartung

  • 1Department of Neurology, Karl-Franzens Universität Graz, Austria. Stefan.Quasthoff@kfunigraz.ac.at

Journal of Neurology
|April 17, 2002
PubMed
Summary

Chemotherapy can cause debilitating peripheral neuropathy, affecting sensory and motor nerves. Current treatments lack effective prevention or cures for this common chemotherapy side effect.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis.

Frontiers in immunology·2026
Same author

Efficacy and safety of risdiplam in adults with 5q-associated spinal muscular atrophy: a nationwide observational cohort study in Austria.

EClinicalMedicine·2025
Same author

Screening for Congenital Myasthenic Syndromes in Adults With Seronegative Myasthenia Gravis Using Next-Generation Sequencing.

Neurology·2025
Same author

Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy.

Annals of clinical and translational neurology·2025
Same author

Two-decade battle with myasthenia gravis: A breakthrough case report on the long-term success with eculizumab and ravulizumab treatment.

Clinical case reports·2024
Same author

Multifocal motor neuropathy as a mimic of amyotrophic lateral sclerosis: Serum neurofilament light chain as a reliable diagnostic biomarker.

Muscle & nerve·2024

Area of Science:

  • Neuroscience
  • Oncology
  • Pharmacology

Background:

  • Peripheral neuropathy is a dose-limiting toxicity of many chemotherapeutic agents.
  • The precise mechanisms underlying chemotherapy-induced neuropathy remain poorly understood.
  • Different chemotherapy drugs induce distinct patterns of neuropathy, affecting sensory, motor, or autonomic nerves.

Purpose of the Study:

  • To review the current understanding of chemotherapy-induced peripheral neuropathy.
  • To highlight the types of neuropathy associated with specific chemotherapeutic agents.
  • To discuss factors influencing neuropathy development and patient recovery.

Main Methods:

  • Literature review of chemotherapy-induced peripheral neuropathy.
  • Analysis of drug-specific neurotoxicity profiles.
  • Examination of predisposing factors and recovery patterns.

Main Results:

  • Chemotherapy-induced neuropathy presents as sensory, sensorimotor, or mixed with autonomic involvement.
  • Neurotoxicity is dependent on cumulative dose and drug type, with some cases arising after single applications.
  • Pre-existing nerve damage (e.g., diabetes, alcohol use) increases susceptibility.
  • Recovery is often incomplete, requiring extended regeneration periods.

Conclusions:

  • Chemotherapy-induced peripheral neuropathy is a significant clinical challenge with limited therapeutic options.
  • No universally effective preventive or curative treatments are currently available.
  • Further research into mechanisms and novel therapeutic strategies is crucial.

Related Experiment Videos